Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

18,845 total articles

Scorpio Tankers Inc. Announces Closing of Convertible Senior Notes due 2031 and Concurrent Stock Repurchase

Scorpio Tankers Inc. Announces Closing of Convertible Senior Notes due 2031 and Concurrent Stock Repurchase

Scorpio Tankers Inc. completed a $375 million private offering of convertible senior notes due 2031, including the full exercise of an additional purchase option. Concurrently, the company repurchased approximately 1.34 million shares at $74.36 each. The net proceeds after expenses amount to around $363.3 million, with $100 million used for share r…

Li Auto Inc. Files Its Annual Report on Form 20-F

Li Auto Inc. Files Its Annual Report on Form 20-F

Li Auto Inc., a leading new energy vehicle manufacturer in China, announced the filing of its annual report on Form 20-F for the fiscal year ended December 31, 2025, with the U.S. Securities and Exchange Commission. The company detailed its robust product lineup and ongoing commitment to innovation in electric vehicle technology, including extended…

Nasdaq Announces End-of-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date March 31, 2026

Nasdaq Announces End-of-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date March 31, 2026

Nasdaq released its end-of-month report on open short interest positions as of March 31, 2026, showing an increase in total shares sold short across Nasdaq Global Market and Capital Market securities compared to the previous period. The average days to cover also rose, indicating slightly higher short-selling activity amid stable stock count. Nasda…

Spyre Therapeutics to Host Conference Call to Report SPY001 Part A Induction Topline Results from SKYLINE Trial in Moderate-to-Severe Ulcerative Colitis Patients on April 13, 2026

Spyre Therapeutics to Host Conference Call to Report SPY001 Part A Induction Topline Results from SKYLINE Trial in Moderate-to-Severe Ulcerative Colitis Patients on April 13, 2026

Spyre Therapeutics will report topline induction results from Part A of its SKYLINE clinical trial evaluating SPY001 in moderate-to-severely active ulcerative colitis patients on April 13, 2026. Following the announcement, the company will hold a conference call and webcast to discuss the data. Spyre is a clinical-stage biotech focused on developin…

Barrick to Report First Quarter 2026 Results on May 11

Barrick to Report First Quarter 2026 Results on May 11

Barrick Mining Corporation announced that it will report its first quarter 2026 results before market open on May 11, 2026, followed by a live webcast and Q&A session with analysts. The company is a leading global gold and copper miner with operations in 17 countries, and it is the largest gold producer in the United States.

Concorde International Group Ltd. Announces Ticker Change to "YOOV" Following Acquisition of YOOV Group Holding Limited

Concorde International Group Ltd. Announces Ticker Change to "YOOV" Following Acquisition of YOOV Group Holding Limited

Concorde International Group Ltd., listed on NASDAQ, announced a ticker change from CIGL to YOOV coinciding with its acquisition of YOOV Group Holding Limited. This move marks Concorde's strategic expansion into AI-driven business automation, merging its security technology with YOOV's innovative AI-as-a-Service platform to enhance market reach and…

Aura Announces Preliminary Q1 2026 Production Results, another record high and on track with the Company Guidance

Aura Announces Preliminary Q1 2026 Production Results, another record high and on track with the Company Guidance

Aura Minerals Inc. announced preliminary Q1 2026 production results, achieving a record high of 82,137 gold equivalent ounces (GEO), 37% higher than Q1 2025 and slightly above Q4 2025, in line with company guidance. Despite some mine sequencing impacts and infrastructure upgrades, increased production is expected in the second half of the year acro…

Arqit Quantum Inc. Announces Select Preliminary Financial Results for the First Half of Fiscal Year 2026

Arqit Quantum Inc. Announces Select Preliminary Financial Results for the First Half of Fiscal Year 2026

Arqit Quantum Inc. announced preliminary financial results for the first half of fiscal year 2026, showing revenue growth to approximately $620K-$630K compared to $67K in the prior year period. The increase reflects revenue recognition from existing and newly signed contracts. The company maintains a strong cash position of approximately $28.9 mill…

NeurAxis, Inc. Announces Preferred Stock Dividend

NeurAxis, Inc. Announces Preferred Stock Dividend

NeurAxis, Inc., a medical technology company specializing in neuromodulation therapies for chronic conditions, announced a stock dividend for holders of its Series B Preferred Stock. Shareholders of record on April 21, 2026 will receive common stock dividends payable on April 28, 2026, with approximately 510,605 shares expected to be issued. This m…

Garrett Motion to Hold First Quarter 2026 Financial Results Conference Call on Thursday April 30, 2026

Garrett Motion to Hold First Quarter 2026 Financial Results Conference Call on Thursday April 30, 2026

Garrett Motion Inc., a global leader in turbocharging and electrification technologies, announced it will release its first-quarter 2026 financial results on April 30, 2026, prior to U.S. market opening, followed by a conference call and webcast. The company highlights its ongoing commitment to innovation in automotive turbocharging, hydrogen fuel …

Opus Genetics Announces Data Presentations at the 2026 American Society of Cataract and Refractive Surgery Annual Meeting

Opus Genetics Announces Data Presentations at the 2026 American Society of Cataract and Refractive Surgery Annual Meeting

Opus Genetics announces presentations of three Phase 3 clinical trial data on its phentolamine ophthalmic solution at the 2026 ASCRS Annual Meeting, including full results from VEGA-3 for presbyopia, a post-hoc analysis of MIRA-2 for mydriasis reversal, and LYNX-2 for visual disturbances post-refractive surgery. The company highlights collaboration…

Beneficient Closes $8.75 Million GP Primary Capital Transaction

Beneficient Closes $8.75 Million GP Primary Capital Transaction

Beneficient (NASDAQ: BENF) announced the closing of an $8.75 million primary capital transaction with Quartus AI Fund LP, a fund investing in growth-stage Vertical AI ventures. The transaction provides Quartus with Convertible Preferred Stock in exchange for capital, increasing Beneficient's collateral for its ExAlt loan portfolio by approximately …

Wrap Lands Major Pre-Order for Over 20 Drone and Counter-Drone Systems, Advancing Expansion Across the U.K. and Europe

Wrap Lands Major Pre-Order for Over 20 Drone and Counter-Drone Systems, Advancing Expansion Across the U.K. and Europe

Wrap Technologies announced a purchase order from Advanced Blast & Ballistic Systems Group for 20 MERLIN-1 Counter-UAS drone systems targeting the UK public safety market. This order marks a key milestone in Wrap's international drone portfolio expansion and is a step toward broader adoption across the UK and Europe. The MERLIN-1 platform offers a …